![Massimo Cristofanilli: Development of endocrine resistance can be associated with loss of ER expression in CTCs](https://oncodaily.com/pub/uploads/2024/04/download-88.jpg)
Photo taken from Massimo Cristofanilli/X
Apr 13, 2024, 07:26
Massimo Cristofanilli: Development of endocrine resistance can be associated with loss of ER expression in CTCs
Massimo Cristofanilli, Dana-Farber’s Breast Oncology Center, on X, adding:
at Weill Cornell Medicine, shared a post by“Development of endocrine resistance can be associated with loss of ER expression in CTCs. Expanding liquid biopsy assessment in HR+ MBC. ”
Quoting Dana-Farber’s Breast Oncology Center’s post:
“Results of the Phase II PACE Study: Characterization of estrogen receptor expression on CTCs during CDK4/6i treatment in HR+/HER2- Metastatic Breast Cancer were presented at AACR24.”
Read further.
Source: Massimo Cristofanilli/X and Dana-Farber’s Breast Oncology Center/X